We previously reported that patients with hyperalphalipoproteinemia (HALP) caused by CETP deficiency (CETP-D), who also showed similar lipid profiles to CETP inhibitor-treated patients, were not protected against CVD[9]. Here, CETP is linked to hyperalphalipoproteinemia.